Latest filing published 01 Mar 2018 for CYTOKINETICS INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -7.6%Entry US$64.40 · Close at T+365 US$59.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Peter S. Roddy: trading record in brief
Peter S. Roddy has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Filana Therapeutics, Inc., Aspira Women's Health Inc. and Cytokinetics Inc. The record holds 69 filings, for trades running from 9 February 2006 to 27 February 2018.
On the open market, the record shows 25 purchases worth €584k and 17 sales worth €1.2M. Taken together, the sales exceed the purchases by €616k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 14 share grants and 1 option exercise.
A typical purchase (the median) is worth €24k.
The record was last updated on 1 March 2018 with a share grant in Cytokinetics Inc. The clock since the last published purchase (23 December 2014) now reads 4,338 days. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter S. Roddy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares0Common StockSEC:0001061983-18-000018:0
- 33,182 shares0Common StockSEC:0001233531-16-000004:0
- 18,386 shares0Common StockSEC:0001573723-16-000014:0
- 47,403 shares0Common StockSEC:0001233531-16-000003:0
- 26,340 shares0Common StockSEC:0001233531-15-000002:0
- 171,591 shares@ US$4.54Common StockSEC:0001573723-14-000019:0
- 153,050 shares@ US$5.09Common StockSEC:0001573723-14-000019:1
- 25,000 shares0Common StockSEC:0001233531-14-000001:0
- 26,660 shares0Common StockSEC:0001233531-13-000001:0
- 2,604 shares@ US$1.92(1) Common StockSEC:0001573723-13-000002:0
- 596 shares@ US$2.51Common Stock (1)SEC:0001245261-12-000019:0
- 11,032 shares0Common Stock (1)SEC:0001245261-12-000015:0
- 36,000 shares0Common StockSEC:0001181431-12-030748:0
- 4,346 shares@ US$3.45Common stock (1)SEC:0001245261-12-000002:0
- 11,032 shares0Common stock (1)SEC:0001245261-11-000032:0
- 192 shares@ US$3.86Common stock (1)SEC:0001245261-11-000029:0
- 5,228 shares@ US$2.87Common StockSEC:0001245261-11-000008:0
- 7,000 shares0Common StockSEC:0001245261-11-000008:1
- 18,200 shares0Common StockSEC:0001181431-11-019956:0
- 12,465 shares0Common StockSEC:0001245261-11-000003:0
- 15,500 shares0Common StockSEC:0001181431-10-060823:0
- 1,661 shares@ US$3.77Common StockSEC:0001245261-10-000046:0
- 3,983 shares@ US$3.77Common StockSEC:0001245261-10-000019:0
- 3,983 shares@ US$3.77Common StockSEC:0001245261-10-000017:0Canonical exit: 30 Jul 2010 (T+90)
- 8,630 shares0Common StockSEC:0001245261-10-000002:0
25 of 68 declarations
